Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC
Condition: Locally Advanced Non-Small Cell Lung Cancer Interventions: Drug: Atovaquone Oral Suspension; Drug: Standard of care chemotherapy; Radiation: Standard of care radiotherapy Sponsors: University of Oxford; Cancer Research UK; National Institute for Health Research, United Kingdom; NHS Lothian; Oxford University Hospitals NHS Trust; NHS Research Scotland Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials